Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples